These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 24150255)

  • 1. Antidiabetic sulfonylureas and cAMP cooperatively activate Epac2A.
    Takahashi T; Shibasaki T; Takahashi H; Sugawara K; Ono A; Inoue N; Furuya T; Seino S
    Sci Signal; 2013 Oct; 6(298):ra94. PubMed ID: 24150255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs.
    Zhang CL; Katoh M; Shibasaki T; Minami K; Sunaga Y; Takahashi H; Yokoi N; Iwasaki M; Miki T; Seino S
    Science; 2009 Jul; 325(5940):607-10. PubMed ID: 19644119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperation between cAMP signalling and sulfonylurea in insulin secretion.
    Shibasaki T; Takahashi T; Takahashi H; Seino S
    Diabetes Obes Metab; 2014 Sep; 16 Suppl 1():118-25. PubMed ID: 25200305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exchange protein directly activated by cyclic AMP isoform 2 is not a direct target of sulfonylurea drugs.
    Tsalkova T; Gribenko AV; Cheng X
    Assay Drug Dev Technol; 2011 Feb; 9(1):88-91. PubMed ID: 21133673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Epac2A/Rap1 signaling in interplay between incretin and sulfonylurea in insulin secretion.
    Takahashi H; Shibasaki T; Park JH; Hidaka S; Takahashi T; Ono A; Song DK; Seino S
    Diabetes; 2015 Apr; 64(4):1262-72. PubMed ID: 25315008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of the N-terminal cyclic AMP-binding domain of Epac2 in its subcellular localization and function.
    Niimura M; Miki T; Shibasaki T; Fujimoto W; Iwanaga T; Seino S
    J Cell Physiol; 2009 Jun; 219(3):652-8. PubMed ID: 19170062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recruitment of Epac2A to Insulin Granule Docking Sites Regulates Priming for Exocytosis.
    Alenkvist I; Gandasi NR; Barg S; Tengholm A
    Diabetes; 2017 Oct; 66(10):2610-2622. PubMed ID: 28679628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct activation of Epac by sulfonylurea is isoform selective.
    Herbst KJ; Coltharp C; Amzel LM; Zhang J
    Chem Biol; 2011 Feb; 18(2):243-51. PubMed ID: 21338921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidiabetic sulfonylureas modulate farnesoid X receptor activation and target gene transcription.
    Steri R; Kara M; Proschak E; Steinhilber D; Schneider G; Schubert-Zsilavecz M
    Future Med Chem; 2010 Apr; 2(4):575-86. PubMed ID: 21426008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and regulation of the cAMP-binding domains of Epac2.
    Rehmann H; Prakash B; Wolf E; Rueppel A; de Rooij J; Bos JL; Wittinghofer A
    Nat Struct Biol; 2003 Jan; 10(1):26-32. PubMed ID: 12469113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic adenosine 5'-monophosphate-stimulated neurotensin secretion is mediated through Rap1 downstream of both Epac and protein kinase A signaling pathways.
    Li J; O'Connor KL; Cheng X; Mei FC; Uchida T; Townsend CM; Evers BM
    Mol Endocrinol; 2007 Jan; 21(1):159-71. PubMed ID: 17068197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic β-cell response to increased metabolic demand and to pharmacologic secretagogues requires EPAC2A.
    Song WJ; Mondal P; Li Y; Lee SE; Hussain MA
    Diabetes; 2013 Aug; 62(8):2796-807. PubMed ID: 23578994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitation of ß-cell K(ATP) channel sulfonylurea sensitivity by a cAMP analog selective for the cAMP-regulated guanine nucleotide exchange factor Epac.
    Leech CA; Dzhura I; Chepurny OG; Schwede F; Genieser HG; Holz GG
    Islets; 2010; 2(2):72-81. PubMed ID: 20428467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B.
    Rehmann H; Arias-Palomo E; Hadders MA; Schwede F; Llorca O; Bos JL
    Nature; 2008 Sep; 455(7209):124-7. PubMed ID: 18660803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor.
    Rangarajan S; Enserink JM; Kuiperij HB; de Rooij J; Price LS; Schwede F; Bos JL
    J Cell Biol; 2003 Feb; 160(4):487-93. PubMed ID: 12578910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state.
    Rehmann H; Das J; Knipscheer P; Wittinghofer A; Bos JL
    Nature; 2006 Feb; 439(7076):625-8. PubMed ID: 16452984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional roles of protein kinase A (PKA) and exchange protein directly activated by 3',5'-cyclic adenosine 5'-monophosphate (cAMP) 2 (EPAC2) in cAMP-mediated actions in adrenocortical cells.
    Aumo L; Rusten M; Mellgren G; Bakke M; Lewis AE
    Endocrinology; 2010 May; 151(5):2151-61. PubMed ID: 20233795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial control of Epac2 activity by cAMP and Ca2+-mediated activation of Ras in pancreatic β cells.
    Idevall-Hagren O; Jakobsson I; Xu Y; Tengholm A
    Sci Signal; 2013 Apr; 6(273):ra29.1-11, S1-6. PubMed ID: 23633676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Rap1 dominant-negative mutants interfere selectively with C3G and Epac.
    Dupuy AG; L'Hoste S; Cherfils J; Camonis J; Gaudriault G; de Gunzburg J
    Oncogene; 2005 Jun; 24(28):4509-20. PubMed ID: 15856025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epac: a new cAMP target and new avenues in cAMP research.
    Bos JL
    Nat Rev Mol Cell Biol; 2003 Sep; 4(9):733-8. PubMed ID: 14506476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.